CCPA Sends Comments to Congress on the Dangers of MFN Pricing Models
The Chronic Care Policy Alliance (CCPA) recently submitted letters to the Senate HELP and Finance Committees, as well as the House Ways and Means and Energy and Commerce Committees, opposing…
Liz Helms, CEO of the Chronic Care Policy Alliance (CCPA), issued the following statement on Most Favored Nation pricing: “Most Favored Nation (MFN) pricing is not a patient-centered solution and will likely…
Webinar Recap: Drug Pricing Reform: What Patients Need to Know
On April 9, 2026, CCPA hosted “Drug Pricing Reform: What Patients Need to Know,” a webinar moderated by CCPA CEO Liz Helms. The panel featured Sue Peschin and Adina Lasser…
